Editorial · 1 May 2020
EditorialPublished 17 May 2016
Atherosclerosis and Lipid Lowering: is there a Need for New Agents?
1Department of Clinical Research, Federal University of Uberlandia, Brazil; 2Department of Medico Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy; 3Eleonora Lorillard Spencer Cenci Foundation, Rome, Italy
Keywords
Subjects
CardiologySimilar by topic
Review article · 6 Mar 2023
Lowering LDL-C: What it means for atherosclerosis and how low to go
Review article · 29 Jul 2022
Renal Denervation Lowers Atheroprone Endothelial Phenotypes and Atherosclerosis by Targeting the Mitochondria-Inflammation Circle
Short communication · 22 Apr 2022
Atherosclerosis and arteriosclerosis in the lower extremities and cardiovascular risk.
Opinion · 1 Jul 2024
Atherosclerosis: The Role of Inflammation and Lipid Metabolism
More from this journal
The newest in Atherosclerosis: Open Access.
Editorial · 31 Mar 2025
Low-Density Lipoprotein (LDL): The “Bad Cholesterol” and Cardiovascular Risk
Editorial · 31 Mar 2025
Understanding Dyslipidemia: Causes, Risks, and Management
Editorial · 31 Mar 2025
Diabetes and Atherosclerosis: A Dangerous Partnership in Cardiovascular Disease
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalAtherosclerosis: Open Access
- SubjectCardiology
- BylineArticles whose byline prints “Leonardo Roever”
- BylineArticles whose byline prints “Elmiro Santos Resende”
- BylineArticles whose byline prints “Giuseppe Biondi-Zoccai”
